Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2): A Perspective Through the Lens of the Veterinary Diagnostic Laboratory

被引:3
|
作者
Stokol, Tracy [1 ]
McAloose, Denise [2 ]
Terio, Karen A. [3 ]
Salguero, Francisco J. [4 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA
[2] Bronx Zoo, Zool Hlth Program, Wildlife Conservat Soc, Bronx, NY USA
[3] Univ Illinois, Zool Pathol Program, Dept Vet Clin Med, Coll Vet Med, Brookfield, IL USA
[4] Publ Hlth England, Salisbury, Wilts, England
关键词
COVID-19; diagnostic testing; serology; molecular genetics; viral infection; wildlife; zoological animals; public safety; INFECTION;
D O I
10.3389/fvets.2020.576267
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The SARS-CoV-2 pandemic has resulted in unprecedented challenges to veterinary diagnostic laboratories. These challenges include partial or complete shutdowns, interrupted courier services, disruptions in workflow and diagnostic testing, new physical distancing practices, protocol development or enhancement for handling samples from high-risk or susceptible species, and fulfilling requirements for pre-test permission approval from state and federal veterinary agencies, all of which have been implemented to prevent or minimize exposure and transmission of SARS-CoV-2 locally or regionally. As in people, SARS-CoV-2 infects animals through direct animal-to-animal contact and aerosol transmission between animals. Humans can also infect pets or other animals in their care and, although human-to-human transmission is the main route of viral spread in people, infected animals and specimens of their bodily fluids or tissues are a potential source of infection for veterinarians and technical or laboratory personnel that are handling them. In this perspective, we discuss how SARS-CoV-2 has necessitated rapid changes in laboratory operation to minimize zoonotic risk to personnel and to implement tests for identifying the virus in animals. The pandemic has highlighted the adaptability and quick response of veterinary diagnosticians to an emerging infectious disease and their critical role in maintaining animal health, while synergizing with and protecting human public health.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Dog in Connecticut in February 2021
    Lee, Dong-Hun
    Helal, Zeinab H.
    Kim, Junwon
    Hunt, Amelia
    Barbieri, Alyza
    Tocco, Natalie
    Frasca, Salvatore, Jr.
    Kerr, Kirklyn
    Hyeon, Ji-Yeon
    Chung, David H.
    Risatti, Guillermo
    VIRUSES-BASEL, 2021, 13 (11):
  • [42] Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Kouhpayeh, Hamidreza
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (08) : 4219 - 4227
  • [43] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?
    Rai, Nitin
    Baidya, Dalim Kumar
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (02) : 245 - 246
  • [44] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
    Wambier, Carlos Gustavo
    Goren, Andy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 308 - 309
  • [45] The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
    Mirzaei, Rasoul
    Mahdavi, Farzad
    Badrzadeh, Fariba
    Hosseini-Fard, Seyed Reza
    Heidary, Maryam
    Jeda, Ali Salimi
    Mohammadi, Tayeb
    Roshani, Mahdane
    Yousefimashouf, Rasoul
    Keyvani, Hossein
    Darvishmotevalli, Mohammad
    Sani, Melika Zarei
    Karampoor, Sajad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [46] A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Istuti Saraswat
    Sarmistha Saha
    Anuja Mishra
    Toxicology and Environmental Health Sciences, 2023, 15 : 315 - 324
  • [47] Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Zhang, Chao
    Zhou, Chenliang
    Shi, Li
    Liu, Ge
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2366 - 2369
  • [48] BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review
    Stack, Michael
    Sacco, Keith
    Castagnoli, Riccardo
    Livinski, Alicia A.
    Notarangelo, Luigi D.
    Lionakis, Michail S.
    CLINICAL IMMUNOLOGY, 2021, 230
  • [49] Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Wong, Sally Cheuk Ying
    Tse, Herman
    Siu, Hon Kei
    Kwong, Tsz Shan
    Chu, Man Yee
    Yau, Felix Yat Sun
    Cheung, Ingrid Yu Ying
    Tse, Cindy Wing Sze
    Poon, Kin Chiu
    Cheung, Kwok Chi
    Wu, Tak Chiu
    Chan, Johnny Wai Man
    Cheuk, Wah
    Lung, David Christopher
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (11) : 2939 - 2946
  • [50] BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review
    Stack, Michael
    Sacco, Keith
    Livinski, Alicia
    Notarangelo, Luigi
    Lionakis, Michail
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S18 - S18